Testosterone implants in women: pharmacological dosing for a physiologic effect

Area of Science:

• Endocrinology
• Pharmacology

Background:

• Subcutaneous testosterone (T) implants are used to treat androgen deficiency symptoms in women.
• Understanding therapeutic serum T levels and their variance is crucial for effective treatment.

Purpose of the Study:

• To determine therapeutic serum testosterone levels and ranges in women using subcutaneous T implants.
• To assess inter-individual variance in serum T levels during T replacement therapy.

Main Methods:

• Serum T levels were measured in pre- and post-menopausal women at four weeks post-insertion and upon symptom return.
• Pharmacokinetic analysis involved measuring T levels at baseline, 4, and 16 weeks after a 100mg T implant.
• Intra-individual circadian variation was assessed over a 26-hour period.

Main Results:

• Serum T levels were significantly higher than endogenous levels, both at four weeks and when symptoms returned.
• High inter-individual variance in T levels was observed (CV 35.9%-42.6%) even with identical dosing.
• Significant intra-individual circadian variation in T levels was also noted (CV 25%).

Conclusions:

• Pharmacologic dosing of subcutaneous T is necessary for a physiological effect in female patients.
• Therapy should be guided by safety, tolerability, and clinical response, not by single, highly variable T measurements.